SMTL ID : 2cji.1

Crystal structure of a Human Factor Xa inhibitor complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

hetero-1-1-mer

Ligands

1 x CA: CALCIUM ION(Non-covalent)

CA.1: 4 residues within 4Å: Chain A: D.56, N.58, Q.61, E.66 6 PLIP interactions: 4 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:D.56, A:N.58, A:Q.61, A:E.66, H2O.1, H2O.1

1 x GSK: 6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE(Non-covalent)

GSK.2: 18 residues within 4Å: Chain A: K.82, E.83, T.84, Y.85, F.162, D.179, A.180, Q.182, S.185, V.203, S.204, W.205, G.206, G.208, C.209, G.216, I.217, Y.218 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:F.162, A:V.203, A:W.205 Hydrogen bonds: A:G.206

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Watson, N.S. et al., Design and Synthesis of Orally Active Pyrrolidin-2-One-Based Factor Xa Inhibitors. Bioorg.Med.Chem.Lett. (2006)

Release Date

2006-05-17

Peptides

ACTIVATED FACTOR XA HEAVY CHAIN: A
FACTOR X LIGHT CHAIN: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

ACTIVATED FACTOR XA HEAVY CHAIN

FACTOR X LIGHT CHAIN

Related Entries With Identical Sequence